TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29280763

Group type: EXPERIMENTAL
Intervention: 10-mg diazepam capsules
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 49
Study: 29462827

Group type: EXPERIMENTAL
Intervention: Uniportal VATS
Number of subjects: 135

Group type: COMPARATOR
Intervention: Two-port VATS
Number of subjects: 135

Group type: COMPARATOR
Intervention: Three-port VATS
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Overall recurrence rate
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Amount of drainage
Number of subjects: 135
Study: 27321474

Group type: EXPERIMENTAL
Intervention: 100 mg oral progesterone daily
Number of subjects: 591

Group type: COMPARATOR
Intervention: No progesterone support
Number of subjects: 591
Study: 23348061

Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Functional training
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 62

Group type: COMPARATOR
Intervention: Motivation (autonomous vs controlled)
Number of subjects: 62
Study: 22133703

Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted vaginal hysterectomy (LAVH)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Total abdominal hysterectomy (TAH)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: LAVH
Number of subjects: 50

Group type: COMPARATOR
Intervention: TAH
Number of subjects: 50
Study: 20018535

Group type: EXPERIMENTAL
Intervention: Intrathecal methylprednisolone (60 mg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 19393151

Group type: EXPERIMENTAL
Intervention: Mayo Clinic STEMI protocol during regular hours (n=258)
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Mayo Clinic STEMI protocol during off hours (n=258)
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Mayo Clinic STEMI protocol during regular hours (n=105)
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Mayo Clinic STEMI protocol during off hours (n=105)
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Fibrinolytic therapy during regular hours (n=131)
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Fibrinolytic therapy during off hours (n=131)
Number of subjects: 597
Study: 16157799

Group type: EXPERIMENTAL
Intervention: 2 consecutive, abnormal, reliable VF test results
Number of subjects: 68

Group type: COMPARATOR
Intervention: 3 consecutive, abnormal, reliable VF test results
Number of subjects: 68
Study: 12014812

Group type: EXPERIMENTAL
Intervention: Therapeutic community (TC) treatment
Number of subjects: 275
Study: 10064293

Group type: EXPERIMENTAL
Intervention: Risk assessment and recording programme implemented in the study group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nursing interventions in the study group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recording of falls in the study group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no risk assessment or preventive interventions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Injuries related to falls in the control group
Number of subjects: 0
Study: 9454190

Group type: EXPERIMENTAL
Intervention: A2 blood type in patients with glottis cancer
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: A1B blood type in patients with hypopharynx cancer
Number of subjects: 500
Study: 2268489

Group type: EXPERIMENTAL
Intervention: Sulfamethoxazole with albumin added to the peritoneal cavity (250‐500 mg/100 ml)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (without albumin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Albumin added to dialysate
Number of subjects: 0
Study: 7092633

Group type: EXPERIMENTAL
Intervention: Topical timolol maleate 0.5%, one drop every 12 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral acetazolamide 500 mg, every 12 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topical timolol maleate added to oral acetazolamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral acetazolamide added to topical timolol
Number of subjects: 0
Study: 31646623

Group type: EXPERIMENTAL
Intervention: Free nicotine patches
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control group (no nicotine patches)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Follow-up at 6 months after quitting
Number of subjects: 600
Study: 31800634

Group type: EXPERIMENTAL
Intervention: Child protection system involvement
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Family cohesion
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Cultural factors interaction with family violence
Number of subjects: 46
Study: 29081151

Group type: EXPERIMENTAL
Intervention: Hypertonic saline solution (4 ml/kg) with general anesthesia (Group H1)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Hypertonic saline solution (4 ml/kg) with spinal canal anesthesia (Group H2)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Isotonic saline (4 ml/kg) with general anesthesia (Group C1)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Isotonic saline (4 ml/kg) with spinal canal anesthesia (Group C2)
Number of subjects: 120
Study: 25505035

Group type: EXPERIMENTAL
Intervention: 2.5 ml 0.5% bupivacaine plus 0.5 ml (20 mg) methylprednisolone
Number of subjects: 69

Group type: COMPARATOR
Intervention: 2.75 ml normal saline plus 0.25 ml 1% lidocaine without epinephrine (placebo)
Number of subjects: 69
Study: 23790912

Group type: EXPERIMENTAL
Intervention: Pinitol 6.0g
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo equivalent in energy and carbohydrates
Number of subjects: 30
Study: 22855579

Group type: EXPERIMENTAL
Intervention: Thalidomide
Number of subjects: 668

Group type: COMPARATOR
Intervention: No Thalidomide
Number of subjects: 668

Group type: EXPERIMENTAL
Intervention: Low NR3C1 levels at relapse
Number of subjects: 668
Study: 18936867

Group type: EXPERIMENTAL
Intervention: Macroplastique(R) Implantation System (MPQ)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Pelvic floor muscle exercises home program
Number of subjects: 45
Study: 17261567

Group type: EXPERIMENTAL
Intervention: Hamstring tendon (HT) autograft
Number of subjects: 180

Group type: COMPARATOR
Intervention: Patellar tendon (PT) autograft
Number of subjects: 180
Study: 14973800

Group type: EXPERIMENTAL
Intervention: Intravenous quinaprilat (0.08 mg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous isotonic saline solution
Number of subjects: 40
Study: 12575546

Group type: EXPERIMENTAL
Intervention: Qinggan Granule (QGG)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Bushen Granule (BSG)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 66
Study: 9042869

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition enriched with omega-3 fatty acids
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isocaloric control nutrition
Number of subjects: 40
Study: 8037492

Group type: EXPERIMENTAL
Intervention: ACT therapy with ADM, CPA, and tamoxifen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous administration of chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of chemotherapy with G‐CSF or bone marrow transplantation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New promising drugs for chemotherapy such as taxanes
Number of subjects: 0
Study: 3340910

Group type: EXPERIMENTAL
Intervention: Early umbilical cord clamping
Number of subjects: 38

Group type: COMPARATOR
Intervention: Delayed umbilical cord clamping (1 minute)
Number of subjects: 38
Study: 29668720

Group type: EXPERIMENTAL
Intervention: Mechanical periodontal therapy plus adjunctive antibiotics (amoxicillin 500 mg and metronidazole 400 mg, 3x/day for 7 days)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Mechanical periodontal therapy only
Number of subjects: 89
Study: 26500139

Group type: EXPERIMENTAL
Intervention: LEN alone, 10 mg per day, 21 days per 4 weeks (L arm)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: LEN (same schedule) + erythropoietin (EPO) beta, 60,000 U per week (LE arm)
Number of subjects: 131
Study: 25481046

Group type: EXPERIMENTAL
Intervention: NT-proBNP levels assessed prior to cardioversion
Number of subjects: 199
Study: 23609382

Group type: EXPERIMENTAL
Intervention: Memantine (20 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 19839945

Group type: EXPERIMENTAL
Intervention: Operated side
Number of subjects: 40

Group type: COMPARATOR
Intervention: Naïve side
Number of subjects: 40
Study: 19301516

Group type: EXPERIMENTAL
Intervention: Test Dentifrice (0.3% triclosan/2.0% PVM/MA copolymer/0.243% sodium fluoride in a 17% dual silica base)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control Dentifrice (0.243% sodium fluoride in a silica base)
Number of subjects: 77
Study: 16880101

Group type: EXPERIMENTAL
Intervention: PVCAP determined by Doppler echocardiography
Number of subjects: 54
Study: 12644421

Group type: EXPERIMENTAL
Intervention: Post-tetanic count (PTC) in diabetic patients
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Train-of-four (TOF) in diabetic patients
Number of subjects: 36

Group type: COMPARATOR
Intervention: Onset of neuromuscular block after vecuronium (0.1 mg kg(‐1)) in diabetic patients
Number of subjects: 36
Study: 10665616

Group type: EXPERIMENTAL
Intervention: Testosterone therapy
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 9274547

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (2 g/day of elemental calcium)
Number of subjects: 591

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 591
Study: 8436148

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg/d (increased to 40 mg/d if necessary)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Atenolol 50 mg/d (increased to 100 mg/d if necessary)
Number of subjects: 45
Study: 3523346

Group type: EXPERIMENTAL
Intervention: Substitution of immunoglobulins
Number of subjects: 20

Group type: COMPARATOR
Intervention: Radiation therapy
Number of subjects: 20
Study: 31916979

Group type: EXPERIMENTAL
Intervention: CP plus four immunizations with oregovomab (CPO)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Standard six cycle IV carboplatin‐paclitaxel chemotherapy (CP)
Number of subjects: 97
Study: 29575254

Group type: EXPERIMENTAL
Intervention: Paclitaxel (175 mg/m2) and nedaplatin (80 mg/m2) administered every 28 days for 5 cycles after radical hysterectomy
Number of subjects: 62
Study: 27404673

Group type: EXPERIMENTAL
Intervention: tolvaptan treatment for 2 days
Number of subjects: 217

Group type: COMPARATOR
Intervention: conventional treatment
Number of subjects: 217
Study: 24241487

Group type: EXPERIMENTAL
Intervention: adalimumab + MTX
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: adalimumab
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: MTX
Number of subjects: 497
Study: 22527828

Group type: EXPERIMENTAL
Intervention: Balloon Kyphoplasty (BK)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Conservative therapy
Number of subjects: 107
Study: 20015605

Group type: EXPERIMENTAL
Intervention: Gender-responsive treatment (GRT) program using manualized curricula (Helping Women Recover and Beyond Trauma)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Gender-responsive treatment (GRT) program
Number of subjects: 115

Group type: COMPARATOR
Intervention: Standard prison-based therapeutic community
Number of subjects: 115
Study: 18081834

Group type: EXPERIMENTAL
Intervention: 270 microg kg(-1) rFVIIa
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 90 microg kg(-1) rFVIIa (administered at hours 0, 3, and 6)
Number of subjects: 0

Group type: COMPARATOR
Intervention: APCC (75 U kg(-1) at hour 0)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Global response algorithm
Number of subjects: 0
Study: 15879805

Group type: EXPERIMENTAL
Intervention: Shock Wave Lithotripsy (SWL)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Ureteroscopy (URS)
Number of subjects: 78
Study: 12208434

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA) with remifentanil and propofol
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sevoflurane-fentanyl anesthesia (SF)
Number of subjects: 50
Study: 11428976

Group type: EXPERIMENTAL
Intervention: Acyclovir (800 mg qid for 12 weeks)
Number of subjects: 55
Study: 8701375

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin with omeprazole and bismuth
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo with omeprazole and bismuth
Number of subjects: 44
Study: 1837113

Group type: EXPERIMENTAL
Intervention: CB006 (0.4 mg/kg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: CB006 (2 mg/kg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Historical control group (19 patients)
Number of subjects: 14
Study: 6228938

Group type: EXPERIMENTAL
Intervention: Dihydroergotoxine mesylate (DHT) 1.5 mg t.i.d.
Number of subjects: 559

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 559
Study: 30692255

Group type: EXPERIMENTAL
Intervention: LSD
Number of subjects: 25

Group type: COMPARATOR
Intervention: Ketanserin plus LSD
Number of subjects: 25
Study: 29762690

Group type: EXPERIMENTAL
Intervention: Early antiretroviral treatment in HIV‐1‐positive infants
Number of subjects: 109

Group type: COMPARATOR
Intervention: HEU infants (control)
Number of subjects: 109
Study: 26721782

Group type: EXPERIMENTAL
Intervention: Yoga intervention (1-time, 1 hour yoga class with a certified instructor)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control intervention (1-time, 1 hour PowerPoint presentation by an obstetrician)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both groups (Yoga and Control)
Number of subjects: 52
Study: 25164700

Group type: EXPERIMENTAL
Intervention: simeprevir plus peginterferon/ribavirin (simeprevir/PR)
Number of subjects: 848

Group type: COMPARATOR
Intervention: placebo plus peginterferon/ribavirin (placebo/PR)
Number of subjects: 848
Study: 22209388

Group type: EXPERIMENTAL
Intervention: MRC+I (8 individual motivational enhancement sessions and 16 treatment readiness group sessions with monetary incentives)
Number of subjects: 281

Group type: COMPARATOR
Intervention: MRC-only (8 individual motivational enhancement sessions and 16 treatment readiness group sessions)
Number of subjects: 281

Group type: COMPARATOR
Intervention: SRC (standard referral)
Number of subjects: 281
Study: 19114223

Group type: EXPERIMENTAL
Intervention: Wet-cupping care
Number of subjects: 98

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 98
Study: 17767458

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 2
Study: 15688691

Group type: EXPERIMENTAL
Intervention: Modified Nuan Gan Jian Jiao Nang (MNGJ)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 66
Study: 12470747

Group type: EXPERIMENTAL
Intervention: Scleral expansion band (SEB) segments
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control eye (nonoperated)
Number of subjects: 29
Study: 9801679

Group type: EXPERIMENTAL
Intervention: TruPulse laser (Tissue Technologies, Palomar Medical Products Inc, Lexington, Mass)
Number of subjects: 35

Group type: COMPARATOR
Intervention: UltraPulse 5000 laser (Coherent Medical Inc, Palo Alto, Calif)
Number of subjects: 35
Study: 7698680

Group type: EXPERIMENTAL
Intervention: GnRH analog (10 micrograms, 2 intravenous pulses)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: GnRH injection
Number of subjects: 29

Group type: COMPARATOR
Intervention: LH secretion
Number of subjects: 29

Group type: COMPARATOR
Intervention: FSH secretion
Number of subjects: 29
Study: 2668148

Group type: EXPERIMENTAL
Intervention: Human lymphoblastoid interferon (5 million units per m2 three times per week for 6 months)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 64
Study: 338136

Group type: EXPERIMENTAL
Intervention: MA therapy (Adriamycin + Melphalan)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: MAC therapy (Adriamycin + Melphalan + Cyclophosphamide)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Maintenance therapy (Cyclophosphamide + Methotrexate + 5-Fluorouracil) after induction therapy
Number of subjects: 40
Study: 31146789

Group type: EXPERIMENTAL
Intervention: Functional bracing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plaster cast
Number of subjects: 0
Study: 27771973

Group type: EXPERIMENTAL
Intervention: Amisulpride (50 mg)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 26306011

Group type: EXPERIMENTAL
Intervention: Vena cava filter
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pure anticoagulation
Number of subjects: 0
Study: 24279519

Group type: EXPERIMENTAL
Intervention: KM110329
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 21126861

Group type: EXPERIMENTAL
Intervention: Clear carbohydrate drink (CCD) containing 50 g of carbohydrate
Number of subjects: 12

Group type: COMPARATOR
Intervention: Drink containing 50 g of carbohydrate, 15 g of glutamine, and antioxidants (ONS)
Number of subjects: 12
Study: 19638909

Group type: EXPERIMENTAL
Intervention: EIPL‐IPC
Number of subjects: 88

Group type: COMPARATOR
Intervention: IPC
Number of subjects: 88

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 88
Study: 19681254

Group type: EXPERIMENTAL
Intervention: 6% hydrogen peroxide whitening strips (Crest Whitestrips)
Number of subjects: 43

Group type: COMPARATOR
Intervention: 10% carbamide peroxide custom tray (Opalescence 10%)
Number of subjects: 43
Study: 15955273

Group type: EXPERIMENTAL
Intervention: High-dose intravenous immunoglobulins (IVIg)
Number of subjects: 0
Study: 11990976

Group type: EXPERIMENTAL
Intervention: Eyeglass display with natural scenery (V-session)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Static blank screen eyeglass display (B-session)
Number of subjects: 72
Study: 9860780

Group type: EXPERIMENTAL
Intervention: TNK-tPA 40 mg
Number of subjects: 886

Group type: COMPARATOR
Intervention: tPA
Number of subjects: 886

Group type: EXPERIMENTAL
Intervention: TNK-tPA 30 mg
Number of subjects: 886

Group type: EXPERIMENTAL
Intervention: TNK-tPA 50 mg
Number of subjects: 886
Study: 8938250

Group type: EXPERIMENTAL
Intervention: Methyl t-butyl ether (MTBE)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ethyl t-butyl ether (ETBE)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: T-amyl methyl ether (TAME)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: T-butyl alcohol (TBA)
Number of subjects: 10
Study: 2520619

Group type: EXPERIMENTAL
Intervention: ORS with low sodium and high glucose concentration (Na+ 35, glucose 200 mmol/L)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: ORS with high sodium but low glucose concentration (Na+ 60, glucose 111 mmol/L)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: ORS containing glycine and a glucose polymer (Na+ 50, glucose 50, glycine 50 mmol/L)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: ORS with high glucose content
Number of subjects: 116
Study: 5572682

Group type: EXPERIMENTAL
Intervention: Condensed polyphenol inhalation by byssinotic cardroom workers
Number of subjects: 576

Group type: COMPARATOR
Intervention: Condensed polyphenol inhalation by normal control subjects and non-byssinotic cardroom workers
Number of subjects: 576

Group type: COMPARATOR
Intervention: Comparison of mean titres between groups
Number of subjects: 576

Group type: COMPARATOR
Intervention: Duration of employment in non-byssinotic cardroom workers
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Duration of cardroom exposure in byssinotic cardroom workers
Number of subjects: 576
Study: 30900242

Group type: EXPERIMENTAL
Intervention: Pentax Airway Scope (n=68)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Macintosh laryngoscope (n=68)
Number of subjects: 136
Study: 28645986

Group type: EXPERIMENTAL
Intervention: Intervention with a therapist and Kaspar robot
Number of subjects: 40

Group type: COMPARATOR
Intervention: Therapist only (Control)
Number of subjects: 40
Study: 25631505

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 40

Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 40
Study: 23817340

Group type: EXPERIMENTAL
Intervention: Loading dose (30 mg/kg)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional dose (20 mg/kg)
Number of subjects: 46
Study: 21933752

Group type: EXPERIMENTAL
Intervention: Raltegravir once daily (two 400 mg tablets taken together every 24 h)
Number of subjects: 775

Group type: COMPARATOR
Intervention: Raltegravir twice daily (one 400 mg tablet every 12 h)
Number of subjects: 775

Group type: EXPERIMENTAL
Intervention: Raltegravir once daily
Number of subjects: 775

Group type: COMPARATOR
Intervention: Raltegravir twice daily
Number of subjects: 775
Study: 18757172

Group type: EXPERIMENTAL
Intervention: Quadriceps-sparing (QS) approach
Number of subjects: 60

Group type: COMPARATOR
Intervention: Minimal-incision medial parapatellar (MP) approach
Number of subjects: 60
Study: 15603007

Group type: EXPERIMENTAL
Intervention: Computerized typing training
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Keypad training
Number of subjects: 32
Study: 10591939

Group type: EXPERIMENTAL
Intervention: 125 mm femoral component (group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 100 mm femoral component (group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comparison of both groups
Number of subjects: 60
Study: 8580574

Group type: EXPERIMENTAL
Intervention: Low-protein diet (LPD; median 0.84 g.kg-1.day-1)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Medium-protein diet (MPD; median 1.33 g.kg-1.day-1)
Number of subjects: 10

Group type: COMPARATOR
Intervention: High-protein diet (HPD; median 2.05 g.kg-1.day-1)
Number of subjects: 10
Study: 2406856

Group type: EXPERIMENTAL
Intervention: Bismuth subsalicylate (BSS) at a dosage of 100 mg/(kg.d) for 5 days
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study: 7363645

Group type: EXPERIMENTAL
Intervention: Mianserin
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 31926000

Group type: EXPERIMENTAL
Intervention: ASP8062 (single ascending doses)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: ASP8062 (multiple ascending doses for 14 days)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: ASP8062 (single dose arm for PK assessment)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: ASP8062 (safety assessment)
Number of subjects: 112
Study: 31793540

Group type: EXPERIMENTAL
Intervention: Pantogam (hopantenic acid)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Standardized treatment and placebo
Number of subjects: 87